TW200736397A - Method of protein production using anti-senescence compounds - Google Patents

Method of protein production using anti-senescence compounds

Info

Publication number: TW200736397A
Authority: TW; Taiwan
Prior art keywords: cell culture; protein production; senescence; senescence compound; culture medium
Prior art date: 2005-10-24

Application number

TW095139179A

Other languages

English (en)

Inventor

Yen-Tung Luan

Wen-Ge Wang

Paul Thoday

Denis Drapeau

Judy Chou

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-24

Filing date

2006-10-24

Publication date

2007-10-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37873105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200736397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-24 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-10-01 Publication of TW200736397A publication Critical patent/TW200736397A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Pyridine Compounds (AREA)

TW095139179A 2005-10-24 2006-10-24 Method of protein production using anti-senescence compounds TW200736397A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US72957305P	2005-10-24	2005-10-24

Publications (1)

Publication Number	Publication Date
TW200736397A true TW200736397A (en)	2007-10-01

Family

ID=37873105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095139179A TW200736397A (en)	2005-10-24	2006-10-24	Method of protein production using anti-senescence compounds

Country Status (23)

Country	Link
US (1)	US20070110743A1 (zh)
EP (1)	EP1941026B1 (zh)
JP (2)	JP2009512459A (zh)
KR (1)	KR101402634B1 (zh)
CN (1)	CN101297027B (zh)
AR (1)	AR058140A1 (zh)
AU (1)	AU2006306433B2 (zh)
BR (1)	BRPI0617744A2 (zh)
CA (1)	CA2627003C (zh)
CR (1)	CR9897A (zh)
DK (1)	DK1941026T3 (zh)
EC (1)	ECSP088395A (zh)
ES (1)	ES2485374T3 (zh)
IL (1)	IL190550A (zh)
NI (1)	NI200800111A (zh)
NO (1)	NO20081622L (zh)
PE (1)	PE20070796A1 (zh)
PL (1)	PL1941026T3 (zh)
PT (1)	PT1941026E (zh)
RU (1)	RU2491347C2 (zh)
SI (1)	SI1941026T1 (zh)
TW (1)	TW200736397A (zh)
WO (1)	WO2007050498A2 (zh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2041270T3 (pl)	2006-07-13	2014-04-30	Wyeth Llc	Wytwarzanie glikoprotein
EP2500413A1 (en)	2006-09-13	2012-09-19	Abbott Laboratories	Cell culture improvements
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
TW200902708A (en) *	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
NZ592097A (en)	2008-10-20	2013-01-25	Abbott Lab	Viral inactivation during purification of il-12 and il-18 antibodies
US8895709B2 (en)	2008-10-20	2014-11-25	Abbvie Inc.	Isolation and purification of antibodies using protein A affinity chromatography
US8859235B2 (en)	2009-08-14	2014-10-14	Basf Se	Methods in cell cultures, and related inventions, employing certain additives
EP2601287B1 (en)	2010-08-05	2015-01-07	Amgen Inc.	Dipeptides to enhance yield and viability from cell cultures
EP2611904A2 (en) *	2010-08-31	2013-07-10	Friesland Brands B.V.	Culture medium for eukaryotic cells
EP2702077A2 (en)	2011-04-27	2014-03-05	AbbVie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
TW201247874A (en) *	2011-05-25	2012-12-01	United Biomedical Inc	Method for producing the activity of bone activating protein
US9505833B2 (en)	2012-04-20	2016-11-29	Abbvie Inc.	Human antibodies that bind human TNF-alpha and methods of preparing the same
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Protein purification methods to reduce acidic species
WO2013176754A1 (en)	2012-05-24	2013-11-28	Abbvie Inc.	Novel purification of antibodies using hydrophobic interaction chromatography
SG11201504249XA (en)	2012-09-02	2015-07-30	Abbvie Inc	Methods to control protein heterogeneity
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
MX360649B (es) *	2013-03-13	2018-11-12	Anteis Sa	Péptidos para el rejuvenecimiento de la piel y métodos de uso de los mismos.
US8921526B2 (en)	2013-03-14	2014-12-30	Abbvie, Inc.	Mutated anti-TNFα antibodies and methods of their use
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en)	2013-03-14	2016-11-22	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
EP2970875B2 (en)	2013-03-15	2025-11-26	F. Hoffmann-La Roche AG	Cell culture compositions with antioxidants and methods for polypeptide production
US9598667B2 (en)	2013-10-04	2017-03-21	Abbvie Inc.	Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
MX374124B (es)	2013-10-16	2025-03-05	Outlook Therapeutics Inc	Formulaciones de tampón para la estabilidad de anticuerpo mejorada.
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
CN104398398A (zh) *	2014-10-27	2015-03-11	陈少威	一种细胞量子动力素(平衡剂)及其使用方法
MA40864A (fr) *	2014-10-31	2017-09-05	Biogen Ma Inc	Hypotaurine, gaba, bêta-alanine et choline pour la régulation de l'accumulation de sous-produits résiduaires dans des procédés de culture de cellules mammifères
EP3247718B1 (en)	2015-01-21	2021-09-01	Outlook Therapeutics, Inc.	Modulation of charge variants in a monoclonal antibody composition
TWI870789B (zh)	2015-08-04	2025-01-21	美商再生元醫藥公司	補充牛磺酸之細胞培養基及用法
WO2017083224A1 (en)	2015-11-09	2017-05-18	Bristol-Myers Squibb Company	Methods to manipulate quality attributes of polypeptides produced in cho cells
CN109153717A (zh) *	2016-01-06	2019-01-04	安口生物公司	减少单克隆抗体组合物中的高分子量物类、酸性电荷物类和片段
WO2017136433A1 (en)	2016-02-03	2017-08-10	Oncobiologics, Inc.	Buffer formulations for enhanced antibody stability
BR112020003122A2 (pt) *	2017-10-16	2020-08-04	Regeneron Pharmaceuticals, Inc.	métodos e sistemas para controlar condições de meio de cultura celular e para reduzir modificações pós-translação de uma proteína secretada
US12297451B1 (en)	2019-10-25	2025-05-13	Regeneron Pharmaceuticals, Inc.	Cell culture medium
WO2025053166A1 (ja) *	2023-09-05	2025-03-13	味の素株式会社	培地組成物
WO2025142807A1 (ja) *	2023-12-25	2025-07-03	武田薬品工業株式会社	細胞の培養方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8308235D0 (en) *	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US5225539A (en) *	1986-03-27	1993-07-06	Medical Research Council	Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) *	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5530101A (en) *	1988-12-28	1996-06-25	Protein Design Labs, Inc.	Humanized immunoglobulins
ATE194384T1 (de) *	1989-09-12	2000-07-15	Hoffmann La Roche	Tnf-bindende proteine
US5859205A (en) *	1989-12-21	1999-01-12	Celltech Limited	Humanised antibodies
DE69132032T2 (de) *	1990-11-23	2000-12-21	Peptech Ltd., North Ryde	Verzögerung, verhinderung und/oder rückgängigmachen von zellalterung
JP4124480B2 (ja) *	1991-06-14	2008-07-23	ジェネンテック・インコーポレーテッド	免疫グロブリン変異体
RU2245365C2 (ru) *	1994-01-03	2005-01-27	Генентек Инк.	Тромбопоэтин
US5830761A (en) *	1995-06-07	1998-11-03	Genetics Institute, Inc.	Medium and methods for culturing mammalian cho cells
RU2134120C1 (ru) *	1995-06-26	1999-08-10	Безруков Михаил Васильевич	Средство для стабилизации пептидной связи в белковом препарате
DK1143006T3 (da) *	1995-08-18	2008-07-14	Morphosys Ip Gmbh	Vektorer/DNA-sekvenser fra humane kombinatoriske antistofbiblioteker
JP4306813B2 (ja) *	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
US6146847A (en) *	1996-11-01	2000-11-14	Genespan Corporation	Stabilized transient gene expression
WO1998024893A2 (en) *	1996-12-03	1998-06-11	Abgenix, Inc.	TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND Vλ REGIONS AND ANTIBODIES PRODUCED THEREFROM
US20030040095A1 (en) *	2001-03-16	2003-02-27	Achille Arini	Method for the production of pharmaceutically active recombinant proteins
RU2274643C2 (ru) *	2001-04-24	2006-04-20	Иннодженетикс Н.В.	Выделенный оболочечный белок hcv, способ его получения и лекарство, вакцина, фармацевтическая композиция (варианты) его содержащие
KR20050088136A (ko) *	2002-12-23	2005-09-01	브리스톨-마이어스 스큅 컴퍼니	단백질 생산을 위한 포유류 세포 배양 방법
MXPA06004472A (es) *	2003-10-27	2006-06-20	Wyeth Corp	Eliminacion de agregados de atopeso molecular utilizando cromatografia de hidroxiapatita.
WO2005064013A1 (en) *	2003-12-23	2005-07-14	Bart Janssen	The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy
US7335491B2 (en) *	2004-08-27	2008-02-26	Wyeth Research Ireland Limited	Production of anti-abeta
US7300773B2 (en) *	2004-08-27	2007-11-27	Wyeth Research Ireland Limited	Production of TNFR-Ig
US7294484B2 (en) *	2004-08-27	2007-11-13	Wyeth Research Ireland Limited	Production of polypeptides
US7426440B2 (en) *	2004-09-24	2008-09-16	Nutritional Bioscience Ltd.	Repair and protection factor scoring method for bioactive agents

2006
- 2006-10-23 AR ARP060104624A patent/AR058140A1/es unknown
- 2006-10-23 PE PE2006001284A patent/PE20070796A1/es not_active Application Discontinuation
- 2006-10-24 KR KR1020087009856A patent/KR101402634B1/ko not_active Expired - Fee Related
- 2006-10-24 PT PT68442110T patent/PT1941026E/pt unknown
- 2006-10-24 TW TW095139179A patent/TW200736397A/zh unknown
- 2006-10-24 ES ES06844211.0T patent/ES2485374T3/es active Active
- 2006-10-24 DK DK06844211.0T patent/DK1941026T3/da active
- 2006-10-24 EP EP06844211.0A patent/EP1941026B1/en active Active
- 2006-10-24 JP JP2008537834A patent/JP2009512459A/ja not_active Withdrawn
- 2006-10-24 WO PCT/US2006/041256 patent/WO2007050498A2/en not_active Ceased
- 2006-10-24 RU RU2008113220/10A patent/RU2491347C2/ru active
- 2006-10-24 PL PL06844211T patent/PL1941026T3/pl unknown
- 2006-10-24 US US11/585,607 patent/US20070110743A1/en not_active Abandoned
- 2006-10-24 BR BRPI0617744-1A patent/BRPI0617744A2/pt not_active Application Discontinuation
- 2006-10-24 AU AU2006306433A patent/AU2006306433B2/en not_active Ceased
- 2006-10-24 CN CN2006800396267A patent/CN101297027B/zh not_active Expired - Fee Related
- 2006-10-24 CA CA2627003A patent/CA2627003C/en active Active
- 2006-10-24 SI SI200631796T patent/SI1941026T1/sl unknown
2008
- 2008-04-01 IL IL190550A patent/IL190550A/en active IP Right Grant
- 2008-04-02 NO NO20081622A patent/NO20081622L/no not_active Application Discontinuation
- 2008-04-09 NI NI200800111A patent/NI200800111A/es unknown
- 2008-04-18 CR CR9897A patent/CR9897A/es not_active Application Discontinuation
- 2008-04-23 EC EC2008008395A patent/ECSP088395A/es unknown
2013
- 2013-04-26 JP JP2013094315A patent/JP5907928B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CR9897A (es)	2008-07-29
BRPI0617744A2 (pt)	2011-08-02
AU2006306433A1 (en)	2007-05-03
DK1941026T3 (da)	2014-07-21
JP2009512459A (ja)	2009-03-26
AR058140A1 (es)	2008-01-23
JP5907928B2 (ja)	2016-04-26
NO20081622L (no)	2008-06-18
IL190550A (en)	2017-01-31
IL190550A0 (en)	2008-11-03
EP1941026B1 (en)	2014-06-04
CN101297027A (zh)	2008-10-29
PE20070796A1 (es)	2007-08-15
PL1941026T3 (pl)	2014-12-31
CN101297027B (zh)	2013-04-03
AU2006306433B2 (en)	2013-04-18
US20070110743A1 (en)	2007-05-17
KR20080063365A (ko)	2008-07-03
HK1120552A1 (zh)	2009-04-03
ES2485374T3 (es)	2014-08-13
CA2627003A1 (en)	2007-05-03
EP1941026A2 (en)	2008-07-09
RU2491347C2 (ru)	2013-08-27
RU2008113220A (ru)	2009-12-10
KR101402634B1 (ko)	2014-06-03
SI1941026T1 (sl)	2014-07-31
ECSP088395A (es)	2008-05-30
NI200800111A (es)	2009-03-03
JP2013165728A (ja)	2013-08-29
PT1941026E (pt)	2014-07-31
WO2007050498A2 (en)	2007-05-03
WO2007050498A3 (en)	2007-07-12
CA2627003C (en)	2018-08-28

Publication	Publication Date	Title
TW200736397A (en)	2007-10-01	Method of protein production using anti-senescence compounds
MX2009011363A (es)	2009-11-05	Metodo de produccion de proteinas utilizando compuestos anti-senectud.
MY156588A (en)	2016-03-15	Systems using cell culture for production of isoprene
NZ597334A (en)	2014-02-28	Cell culture improvements
DK1623023T3 (da)	2009-03-02	Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra
WO2008060541A3 (en)	2008-08-28	In vitro expansion of postpartum-derived cells using microcarriers
WO2014143744A3 (en)	2015-11-05	Benzylisoquinoline alkaloids (bia) producing microbes, and methods of making and using the same
MX2009009371A (es)	2009-09-21	Produccion mejorada de derivados de acidos grasos.
NZ593080A (en)	2012-12-21	Novel reagents for transfection of eukaryotic cells
MX2009008416A (es)	2010-01-25	Produccion de biocombustible mediante microorganismos recombinantes.
WO2010045629A3 (en)	2010-08-19	Production of c5-c8 alcohols using evolved enzymes and metabolically engineered microorganisms
WO2008153180A1 (ja)	2008-12-18	脂肪組織由来細胞から肝小葉様細胞塊を得る方法
UA112783C2 (uk)	2016-10-25	СПОСІБ ОДЕРЖАННЯ ЦЕЛЮЛАЗ З ВИКОРИСТАННЯМ МІЦЕЛІАЛЬНОГО ГРИБА, ПРИДАТНОГО ДЛЯ БІОРЕАКТОРА, ЩО МАЄ НИЗЬКИЙ ОБ'ЄМНИЙ КОЕФІЦІЕНТ ПЕРЕНЕСЕННЯ КИСНЮ kLa
WO2009073557A3 (en)	2009-12-30	Biological systems for production of commercially valuable compounds
WO2017051347A3 (en)	2017-05-04	Cells and method of cell culture
WO2011129462A3 (en)	2012-01-12	A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME
UA92157C2 (ru)	2010-10-11	Способ продуцирования гормона роста
PL1720979T3 (pl)	2008-03-31	Zastosowanie podłoża pozbawionego surowicy do hodowli komórkowej do wytwarzania IL-18BP w komórkach ssaków
WO2007042577A3 (en)	2007-06-07	Composition comprising enzymatically digested yeast cells and method of preparing same.
EA201170025A1 (ru)	2011-08-30	Способы повышения жизнеспособности и продукции культуры клеток
WO2008090148A3 (en)	2008-09-18	Improvement of cell growth
TW200716744A (en)	2007-05-01	Genetically modified microorganism and process for production of macrolide compound using the microorganism
WO2009069806A1 (ja)	2009-06-04	テトラピロール化合物の製造方法およびテトラピロール化合物
WO2007056062A3 (en)	2007-08-16	Methods for adapting mammalian cells
WO2020171867A3 (en)	2020-10-29	Engineered biosynthetic pathways for production of 2-oxoadipate by fermentation